Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) EPS (Weighted Average and Diluted) (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.14 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 71.43% to -$0.14 in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.29, a 21.34% increase, with the full-year FY2025 number at -$1.64, down 5.81% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.14 in Q1 2026 for Barinthus Biotherapeutics, up from -$0.27 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.41 in Q2 2022 to a low of -$0.62 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.4 (2024), compared with a mean of -$0.3.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 269.23% in 2022 and later tumbled 805.88% in 2023.
  • Barinthus Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$0.55 in 2022, then grew by 18.18% to -$0.45 in 2023, then dropped by 13.33% to -$0.51 in 2024, then skyrocketed by 47.06% to -$0.27 in 2025, then skyrocketed by 48.15% to -$0.14 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.14 (Q1 2026), -$0.27 (Q4 2025), and -$0.36 (Q3 2025) per Business Quant data.